{"id":"https://openalex.org/W51825763","doi":null,"title":"Pharmacologic prevention of osteoporotic fractures.","display_name":"Pharmacologic prevention of osteoporotic fractures.","alternate_titles":[],"publication_year":2004,"publication_date":"2004-10-01","ids":{"openalex":"https://openalex.org/W51825763","mag":"51825763","pmid":"https://pubmed.ncbi.nlm.nih.gov/15508540"},"language":"en","primary_location":{"id":"pmid:15508540","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15508540","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American family physician","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W51825763"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022258254","display_name":"Thomas M. Zizic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Thomas M Zizic","raw_affiliation_strings":["Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. drzizic@bionicare.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. drzizic@bionicare.com","institution_ids":["https://openalex.org/I145311948"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5022258254"],"corresponding_institution_ids":["https://openalex.org/I145311948"],"apc_list":null,"apc_paid":null,"fwci":6.7751,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.96385909,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"70","issue":"7","first_page":"1293","last_page":"1300"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10071","display_name":"Bone health and osteoporosis research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10071","display_name":"Bone health and osteoporosis research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10694","display_name":"Menopause: Health Impacts and Treatments","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/osteoporosis","display_name":"osteoporosis","score":0.875},{"id":"https://openalex.org/keywords/osteoporotic-fractures","display_name":"osteoporotic fractures","score":0.9110000133514404},{"id":"https://openalex.org/keywords/fracture-prevention","display_name":"fracture prevention","score":0.8849999904632568},{"id":"https://openalex.org/keywords/bisphosphonates","display_name":"bisphosphonates","score":0.9259999990463257},{"id":"https://openalex.org/keywords/risedronate","display_name":"risedronate","score":0.996999979019165},{"id":"https://openalex.org/keywords/alendronate","display_name":"alendronate","score":1.0},{"id":"https://openalex.org/keywords/glucocorticoid-induced-osteoporosis","display_name":"glucocorticoid-induced osteoporosis","score":0.925000011920929},{"id":"https://openalex.org/keywords/hormone-therapy","display_name":"hormone therapy","score":0.7639999985694885},{"id":"https://openalex.org/keywords/teriparatide","display_name":"teriparatide","score":0.9890000224113464},{"id":"https://openalex.org/keywords/raloxifene","display_name":"raloxifene","score":0.9110000133514404},{"id":"https://openalex.org/keywords/salmon-calcitonin","display_name":"salmon calcitonin","score":0.9629999995231628},{"id":"https://openalex.org/keywords/bone-mineral-density","display_name":"bone mineral density","score":0.8629999756813049},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.9419999718666077},{"id":"https://openalex.org/keywords/vertebral-fractures","display_name":"vertebral fractures","score":0.8119999766349792}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9603781700134277},{"id":"https://openalex.org/C2776541429","wikidata":"https://www.wikidata.org/wiki/Q165328","display_name":"Osteoporosis","level":2,"score":0.897926390171051},{"id":"https://openalex.org/C2777308945","wikidata":"https://www.wikidata.org/wiki/Q411781","display_name":"Teriparatide","level":4,"score":0.8502363562583923},{"id":"https://openalex.org/C2779889926","wikidata":"https://www.wikidata.org/wiki/Q425223","display_name":"Raloxifene","level":5,"score":0.794358491897583},{"id":"https://openalex.org/C2776886416","wikidata":"https://www.wikidata.org/wiki/Q4941567","display_name":"Bone mineral","level":3,"score":0.6699627041816711},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47335147857666016},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.4216660261154175},{"id":"https://openalex.org/C2777251235","wikidata":"https://www.wikidata.org/wiki/Q412205","display_name":"Bisphosphonate","level":3,"score":0.41871410608291626},{"id":"https://openalex.org/C2778885795","wikidata":"https://www.wikidata.org/wiki/Q240856","display_name":"Hip fracture","level":3,"score":0.4168063998222351},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3269195556640625},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.10091546177864075},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.059466660022735596},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.05119436979293823},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000068296","descriptor_name":"Risedronic Acid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012968","descriptor_name":"Etidronic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012968","descriptor_name":"Etidronic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D012968","descriptor_name":"Etidronic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015519","descriptor_name":"Bone Density","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015663","descriptor_name":"Osteoporosis, Postmenopausal","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D015663","descriptor_name":"Osteoporosis, Postmenopausal","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015663","descriptor_name":"Osteoporosis, Postmenopausal","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019386","descriptor_name":"Alendronate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019386","descriptor_name":"Alendronate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020845","descriptor_name":"Selective Estrogen Receptor Modulators","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020849","descriptor_name":"Raloxifene Hydrochloride","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020849","descriptor_name":"Raloxifene Hydrochloride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D050723","descriptor_name":"Fractures, Bone","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D050723","descriptor_name":"Fractures, Bone","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:15508540","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15508540","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American family physician","raw_type":"Journal Article"},{"id":"mag:51825763","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15508540","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W48670540","https://openalex.org/W236522014","https://openalex.org/W1512821983","https://openalex.org/W1526826623","https://openalex.org/W1964001203","https://openalex.org/W1966813919","https://openalex.org/W1972488771","https://openalex.org/W1984941837","https://openalex.org/W1985500418","https://openalex.org/W1989637027","https://openalex.org/W1992931986","https://openalex.org/W1999700138","https://openalex.org/W2031400196","https://openalex.org/W2038050797","https://openalex.org/W2045947279","https://openalex.org/W2056885783","https://openalex.org/W2080574746","https://openalex.org/W2102123887","https://openalex.org/W2106286936","https://openalex.org/W2106975935","https://openalex.org/W2112629831","https://openalex.org/W2116705247","https://openalex.org/W2124527463","https://openalex.org/W2126162095","https://openalex.org/W2134460604","https://openalex.org/W2153009489","https://openalex.org/W2153579902","https://openalex.org/W2161837912","https://openalex.org/W2314674563","https://openalex.org/W2321227665","https://openalex.org/W2323830513","https://openalex.org/W2335178464","https://openalex.org/W2336517627"],"related_works":["https://openalex.org/W2047225269","https://openalex.org/W103834054","https://openalex.org/W2042825855","https://openalex.org/W1486738713","https://openalex.org/W2079093990","https://openalex.org/W2136235470","https://openalex.org/W2096935087","https://openalex.org/W2014650488","https://openalex.org/W2004270193","https://openalex.org/W2909408436"],"abstract_inverted_index":{"Osteoporosis":[0],"is":[1,34,56,77,165,191],"characterized":[2],"by":[3],"low":[4],"bone":[5,15,30],"mineral":[6,31],"density":[7,32],"and":[8,62,70,102,113,132,164],"a":[9,29,153],"deterioration":[10],"in":[11,53,60,107,127,133,169,185,195],"the":[12,41,72,86,93,99,109,144,149,159,180],"microarchitecture":[13],"of":[14,51,74,97,111,161,182],"that":[16,33,59,88],"increases":[17],"its":[18],"susceptibility":[19],"to":[20,120,178],"fracture.":[21],"The":[22,49],"World":[23],"Health":[24],"Organization":[25],"defines":[26],"osteoporosis":[27,52,131],"as":[28],"2.5":[35],"standard":[36],"deviations":[37],"or":[38,95,201],"more":[39],"below":[40],"reference":[42],"mean":[43],"for":[44,92,167,193],"healthy,":[45],"young":[46],"white":[47,61,66],"women.":[48,64],"prevalence":[50],"black":[54],"women":[55,67,129,186],"one":[57,125],"half":[58],"Hispanic":[63],"In":[65],"50":[68],"years":[69],"older,":[71],"risk":[73,110,123,160],"osteoporotic":[75],"fracture":[76,122,141],"nearly":[78],"40":[79],"percent":[80],"over":[81],"their":[82],"remaining":[83],"lifetime.":[84],"Of":[85],"drugs":[87],"have":[89],"been":[90,118,176],"approved":[91],"prevention":[94],"treatment":[96],"osteoporosis,":[98],"bisphosphonates":[100,200],"(risedronate":[101],"alendronate)":[103],"are":[104],"most":[105],"effective":[106],"reducing":[108],"vertebral":[112,183],"nonvertebral":[114],"fractures.":[115],"Risedronate":[116],"has":[117,175],"shown":[119,177],"reduce":[121],"within":[124],"year":[126],"postmenopausal":[128],"with":[130,135,171,187],"patients":[134,170,196],"glucocorticoid-induced":[136],"osteoporosis.":[137,173,188],"Hormone":[138],"therapy":[139],"reduces":[140,158],"risk,":[142],"but":[143],"benefits":[145],"may":[146],"not":[147],"outweigh":[148],"reported":[150],"risks.":[151],"Teriparatide,":[152],"recombinant":[154],"human":[155],"parathyroid":[156],"hormone,":[157],"new":[162],"fractures":[163,184],"indicated":[166],"use":[168,194],"severe":[172],"Raloxifene":[174],"lower":[179],"incidence":[181],"Salmon":[189],"calcitonin":[190],"reserved":[192],"who":[197],"cannot":[198],"tolerate":[199],"hormone":[202],"therapy.":[203]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W51825763","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
